By Jeremiah Velasquez, FNP-BC, AGACNP-BC
Founder, Steel City HRT & Weight Loss | Board-Certified Family & Acute Care Nurse Practitioner
NPI: 1841894003

Peptide purity is verified through High-Performance Liquid Chromatography (HPLC) and mass spectrometry conducted by licensed 503A compounding pharmacies under strict federal and state oversight. Research-use-only (RUO) suppliers face no such requirements — their Certificates of Analysis are frequently fabricated, recycled from old batches, or based on low-resolution testing that cannot detect residual solvents, structural isomers, or heavy metal contamination.

99% purity. It sounds like a guarantee — the highest standard a vendor could offer. Until you understand what the remaining 1% can actually contain.

Trifluoroacetic acid. Heavy metals. Structural isomers — molecules that carry the same chemical formula as the peptide you ordered but fold differently, triggering receptor interactions that were never part of any studied protocol. At sufficient concentrations, trifluoroacetic acid alone has demonstrated cytotoxic and immune-reactive properties in peer-reviewed literature. It is a laboratory hazard that requires full handling protocols in research settings.

You've probably never heard of TFA in the context of peptide sourcing. And that is exactly the problem.

The online peptide market is flooded with vendors printing those two words — 99% purity — on product pages and PDF documents they call Certificates of Analysis. The documents look credible. They include lab names, lot numbers, and percentages that look like proof. What they rarely include is an independent verification chain, a current test date, or any regulatory obligation to be accurate at all.

The gray market didn't build these systems to protect you. It built them to sell to you.

Jeremiah Velasquez, FNP-BC, AGACNP-BC, is a board-certified nurse practitioner and the founder of Steel City HRT & Weight Loss. Here is what he sees when he looks at that market — and what he does instead.

What's Actually Wrong with a "Certificate of Analysis" from a Research Supplier?

You did your research. You looked for a COA before buying. You checked the purity percentage and the lab name at the top of the document. That isn't naivety — that's what the gray market has trained buyers to believe constitutes due diligence.

The problem isn't the document. It's the standard — or the complete absence of one — behind it.

Research-use-only, or RUO, is a regulatory classification with one specific meaning: not intended for human use. RUO suppliers operate in a legal gray zone designed for laboratory benchtop research, not clinical application. Within that classification, there is no federal mandate requiring current, independent, third-party testing before a compound ships. A vendor can generate a COA from a single batch tested months or years prior and apply it to every order indefinitely. Or they can produce the document from whole cloth.

What makes this particularly dangerous isn't the fraud — it's the fact that even an honest RUO vendor cannot guarantee what a legitimate pharmacy is legally required to verify. Here is what that gap looks like in practice.

One. COA documents from RUO suppliers carry no regulatory authority. No oversight body verifies them. Anyone with a printer and a lab letterhead can produce one.

Two. A single-batch test doesn't account for lot-to-lot manufacturing variation. The compound in this shipment may have a meaningfully different contamination profile than the one on the tested lot.

Three. Most RUO vendors use overseas synthesis operations where residual solvents — trifluoroacetic acid in particular — are never fully removed, because the additional purification steps cut into already-thin margins.

Four. Structural isomers pass low-resolution purity tests routinely. They look identical to the target compound on a basic assay but behave differently inside a biological system.

The gray market was never designed with clinical application in mind. That's not a bug. It's the definition.

Key takeaway: A Certificate of Analysis from an RUO peptide supplier is a marketing document, not a clinical safety standard — and federal law does not require it to be anything more.

What Does Real Peptide Purity Verification Actually Require?

Here's what most people don't know: legitimate purity verification isn't a single test — it's a layered analytical cascade, each step designed to catch what the previous one cannot.

At a licensed 503A compounding pharmacy — the only legal source for human-grade compounded peptides — every compound undergoes High-Performance Liquid Chromatography, or HPLC, as a minimum standard. HPLC is an analytical separation technique that forces a compound through a pressurized column, sorting its constituent molecules by chemical properties. The resulting chromatographic profile identifies impurities, degradation products, and structural isomers at a resolution that basic purity assays cannot approach.

The second layer is mass spectrometry, or MS. Where HPLC reveals the relative quantities of what is in the compound, mass spectrometry identifies precisely what those substances are — by molecular weight, charge state, and fragmentation signature. Together, HPLC-MS produces a molecular fingerprint unique to that batch.

Then come the additional compliance requirements. Residual solvent testing — including TFA — is not optional under United States Pharmacopeia (USP) 797 standards, the federal framework governing sterile pharmaceutical compounding. According to USP 797, licensed compounding pharmacies must verify potency, sterility, pH, endotoxin levels, and particulate matter through independent testing before any compound is dispensed to a patient.

None of that infrastructure exists in the RUO market. Not a single element of it.

The gap between a gray-market peptide listing and a 503A-compounded peptide isn't primarily regulatory — it's the difference between a chemical manufactured for a lab bench and a therapeutic formulated for a human body.

Key takeaway: Real peptide purity verification requires HPLC and mass spectrometry at minimum, plus residual solvent and endotoxin testing under USP 797 — standards that RUO suppliers face no legal obligation to meet.

What Does Accessing Safe, Clinically Verified Peptide Therapy Actually Look Like?

The solution is a legitimate supply chain — and that requires a licensed clinical provider, not a checkout cart.

Starting with a comprehensive lab panel, followed by a telehealth consultation with a board-certified provider, and ending with pharmacy-dispensed compounds verified through HPLC, mass spectrometry, and residual solvent testing — that is the only pathway that puts a verified compound in your hands. The process is straightforward. First: labs. Actual bloodwork that establishes your baseline, rules out contraindications, and gives your provider a complete clinical picture. Second: your telehealth consult. A licensed provider reviews your results, your goals, and your history, and determines whether peptide therapy is appropriate and which compounds make clinical sense. Third: dispense. If prescribed, your compounds are prepared at a licensed 503A pharmacy, cleared through independent analytical testing, and shipped sealed and sterile directly to your address.

There is a reason this infrastructure doesn't exist in the RUO market: it requires accountability. And accountability is exactly what research-grade vendors are legally structured to avoid.

You have two options. You can source your peptides the way thousands of people do — sorting through online listings, cross-referencing COA PDFs that may or may not reflect what shipped, and hoping the synthesis was clean. Or you can access the same compounds through a system that has a legal obligation to prove it.

Key takeaway: Clinically sound peptide therapy begins with a licensed provider, independent lab testing, and 503A pharmacy-grade compounds verified through HPLC and mass spectrometry — not self-prescribing from research-grade vendors with no clinical accountability.

Why Do Patients Choose Steel City HRT & Weight Loss for Peptide Therapy?

I've personally gotten stuck in the research rabbit hole of peptide sourcing — reading forum threads, evaluating vendor claims, trying to parse what "pharmaceutical grade" actually means when no regulatory authority is checking it. I've been that patient. It's exhausting. And it's dangerous.

Steel City HRT & Weight Loss is LegitScript-certified — the same third-party healthcare verification required by Google and Meta to run health-related advertising. LegitScript doesn't certify good intentions. It audits actual compliance.

Every peptide dispensed through Steel City is sourced exclusively from heavily vetted, strictly regulated US 503A compounding pharmacies. That means exact purity verified by HPLC and mass spectrometry. Proper pH balancing. Total sterility. Endotoxin clearance. No TFA. No residual solvents. No structural isomers passing a low-resolution test and making it into your protocol.

We love a good neighborhood BBQ, but we generally recommend keeping the DIY projects limited to the patio — not your bloodstream.

Steel City operates as a fully telehealth practice, licensed across ten states, which means you can access clinically supervised, pharmacy-grade peptide therapy without a single waiting room, without driving anywhere, and without trying to authenticate a PDF from a vendor who answers to no clinical authority.

Starting with your labs. Followed by your consult. Ending with your compounds — verified, sealed, and delivered.

Ready to Start? Patients Across Our Licensed States Can See a Provider This Week.

You've already done the research most people skip. You know what the gray market looks like — and what it can't prove. Now you know what a legitimate alternative requires.

No waiting rooms. No unanswered questions. No COA document standing in for actual regulatory oversight.

Keep sourcing from vendors with no clinical accountability — or step into a system that is legally obligated to prove what's in the vial. That's not a difficult call.

Labs, consult, optimization. That easy.

It all starts at steelcity-trt.com.

Frequently Asked Questions

Q: What is a Certificate of Analysis (COA), and why isn't one from an RUO vendor enough to verify peptide purity? A: A Certificate of Analysis (COA) is a supplier-generated document summarizing quality testing results on a compound. For research-use-only (RUO) vendors, COAs carry no regulatory authority — they can be fabricated, applied to multiple lots from a single old test, or based on low-resolution assays that miss residual solvents, structural isomers, and heavy metal contamination. Unlike licensed 503A compounding pharmacies, RUO suppliers face no federal mandate for independent third-party verification.

Q: What is trifluoroacetic acid (TFA), and why does it matter for peptide safety? A: Trifluoroacetic acid, or TFA, is a byproduct of the Fmoc solid-phase synthesis process used to manufacture most commercial peptides. In research-grade powders, TFA removal is frequently incomplete because the purification steps reduce synthesis margins. TFA has been associated with cytotoxicity and immune reactivity at sufficient concentrations. Licensed 503A compounding pharmacies are required under USP 797 to test for and eliminate residual TFA before any peptide is dispensed for human use.

Q: What is HPLC, and how does it verify peptide purity? A: High-Performance Liquid Chromatography, or HPLC, is an analytical separation technique that forces a compound through a pressurized column, producing a chromatographic profile that reveals impurities, degradation products, and structural isomers at high resolution. When paired with mass spectrometry, HPLC-MS generates a molecular fingerprint that confirms both the identity and purity of a peptide compound batch. Licensed 503A compounding pharmacies require HPLC-MS as a standard verification step before dispensing.

Q: Is it safe to purchase peptides from online research suppliers? A: Purchasing peptides from RUO online vendors carries significant clinical risk. RUO compounds are not manufactured, tested, or regulated for human use. Without mandatory HPLC verification, residual solvent testing, sterility requirements, and endotoxin clearance — all of which are required for licensed 503A compounding pharmacies — there is no reliable way to confirm compound identity, potency, or contamination status. Clinical supervision and pharmacy-grade sourcing are the only protections against dosing errors and contamination exposure.

Q: Can I access peptide therapy without visiting a clinic in person? A: Yes. Steel City HRT & Weight Loss is a fully telehealth practice — no in-person visit is required at any point. Patients complete a lab panel, attend a telehealth consultation with a board-certified nurse practitioner, and, if a prescription is appropriate, receive pharmacy-grade compounds from a licensed 503A compounding pharmacy shipped directly to their address. Steel City is licensed across ten states and LegitScript-certified.

Q: Is Steel City HRT & Weight Loss available in my state? A: Steel City HRT & Weight Loss is currently licensed in Colorado, Arizona, Washington, Idaho, Maine, Montana, New Hampshire, New Mexico, Arkansas, and Wyoming. All care is delivered via telehealth — no in-office visit required. Patients in any licensed state can complete labs, consult with a board-certified provider, and receive clinically verified, 503A pharmacy-sourced peptide therapy without leaving home.

This content is for informational purposes only and does not constitute medical advice. Consult a licensed provider before beginning any hormone or weight loss therapy. Jeremiah Velasquez, FNP-BC, AGACNP-BC, is a licensed nurse practitioner. Steel City HRT & Weight Loss is a LegitScript-certified telehealth clinic.